281 related articles for article (PubMed ID: 17336562)
1. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.
Pastores GM; Arn P; Beck M; Clarke JT; Guffon N; Kaplan P; Muenzer J; Norato DY; Shapiro E; Thomas J; Viskochil D; Wraith JE
Mol Genet Metab; 2007 May; 91(1):37-47. PubMed ID: 17336562
[TBL] [Abstract][Full Text] [Related]
2. Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.
Arn P; Wraith JE; Underhill L
J Pediatr; 2009 Jun; 154(6):859-64.e3. PubMed ID: 19217123
[TBL] [Abstract][Full Text] [Related]
3. Mucopolysaccharidosis type I.
Wraith JE; Jones S
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up.
Gabrielli O; Clarke LA; Bruni S; Coppa GV
Pediatrics; 2010 Jan; 125(1):e183-7. PubMed ID: 20026495
[TBL] [Abstract][Full Text] [Related]
5. Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I.
Thomas JA; Beck M; Clarke JT; Cox GF
J Inherit Metab Dis; 2010 Aug; 33(4):421-7. PubMed ID: 20532982
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.
D'Aco K; Underhill L; Rangachari L; Arn P; Cox GF; Giugliani R; Okuyama T; Wijburg F; Kaplan P
Eur J Pediatr; 2012 Jun; 171(6):911-9. PubMed ID: 22234477
[TBL] [Abstract][Full Text] [Related]
7. Carpal tunnel syndrome in mucopolysaccharidosis I: a registry-based cohort study.
Viskochil D; Muenzer J; Guffon N; Garin C; Munoz-Rojas MV; Moy KA; Hutchinson DT
Dev Med Child Neurol; 2017 Dec; 59(12):1269-1275. PubMed ID: 28892147
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.
Murphy AM; Lambert D; Treacy EP; O'Meara A; Lynch SA
Arch Dis Child; 2009 Jan; 94(1):52-4. PubMed ID: 18463126
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.
Muñoz-Rojas MV; Bay L; Sanchez L; van Kuijck M; Ospina S; Cabello JF; Martins AM
J Inherit Metab Dis; 2011 Oct; 34(5):1029-37. PubMed ID: 21541721
[TBL] [Abstract][Full Text] [Related]
10. [Mucopolysaccharidosis type I in the Cuban population].
Menéndez-Sainz C; Zaldívar-Muñoz C; González-Quevedo A
Rev Neurol; 2003 Sep 16-30; 37(6):525-8. PubMed ID: 14533069
[TBL] [Abstract][Full Text] [Related]
11. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
[TBL] [Abstract][Full Text] [Related]
12. [Hurler syndrome. Early diagnosis and successful enzyme replacement therapy: a new therapeutic approach. Case report].
Dupont C; El Hachem C; Harchaoui S; Ribault V; Amiour M; Guillot M; Maire I; Froissart R; Guffon-Fouilhoux N
Arch Pediatr; 2008 Jan; 15(1):45-9. PubMed ID: 18162380
[TBL] [Abstract][Full Text] [Related]
13. High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry.
Arn P; Whitley C; Wraith JE; Webb HW; Underhill L; Rangachari L; Cox GF
J Pediatr Surg; 2012 Mar; 47(3):477-84. PubMed ID: 22424341
[TBL] [Abstract][Full Text] [Related]
14. The natural history of MPS I: global perspectives from the MPS I Registry.
Beck M; Arn P; Giugliani R; Muenzer J; Okuyama T; Taylor J; Fallet S
Genet Med; 2014 Oct; 16(10):759-65. PubMed ID: 24675674
[TBL] [Abstract][Full Text] [Related]
15. Early disease progression of Hurler syndrome.
Kiely BT; Kohler JL; Coletti HY; Poe MD; Escolar ML
Orphanet J Rare Dis; 2017 Feb; 12(1):32. PubMed ID: 28193245
[TBL] [Abstract][Full Text] [Related]
16. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
Clarke LA; Giugliani R; Guffon N; Jones SA; Keenan HA; Munoz-Rojas MV; Okuyama T; Viskochil D; Whitley CB; Wijburg FA; Muenzer J
Clin Genet; 2019 Oct; 96(4):281-289. PubMed ID: 31194252
[TBL] [Abstract][Full Text] [Related]
18. Hurler-Scheie phenotype with parental consanguinity. Report of an additional case supporting the concept of genetic heterogeneity.
Kaibara N; Katsuki I; Hotokebuchi T; Takagishi K; Kure T
Clin Orthop Relat Res; 1983 May; (175):233-6. PubMed ID: 6404579
[TBL] [Abstract][Full Text] [Related]
19. [Mucopolysaccharidosis I, Hurler syndrome: a case report].
Amorín M; Carlin A; Prötzel A
Arch Argent Pediatr; 2012 Oct; 110(5):e103-6. PubMed ID: 23070190
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.
Moore D; Connock MJ; Wraith E; Lavery C
Orphanet J Rare Dis; 2008 Sep; 3():24. PubMed ID: 18796143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
